An AI that can be interrupted allows for efficiency. A customer can cut off a long legal disclaimer by saying, "I got it, ...

Discusses 3-Year Topline Results From EMBARK Phase 3 Trial of ELEVIDYS in Duchenne Muscular Dystrophy January 26, ...

This study is the first to provide evidence towards successful implementation and effectiveness of a Birthing on Country service and the wrap around care in a rural setting and supports the urgent ...

Thank you, Robert. With these results, our strong backlog, and the largest maintenance portfolio in the industry, we are confident that our strategy will continue to deliver attractive results in 2026 ...

Cash & Bullion $232 million - $58 million increase for the quarterPERTH, Australia, Jan. 29, 2026 (GLOBE NEWSWIRE) -- Alkane Resources Limited (ASX:ALK; TSX:ALK; OTCQX:ALKEF) ('Alkane' or 'the Company ...

Quest Diagnostics reaffirmed as a buy: organic growth, macro demand, strong margins, investment-grade ratings, and dividend ...

Central retinal artery occlusion can result in permanent vision loss. Effective treatment is lacking. We conducted a phase 3, double-blind, double-dummy, randomized, controlled trial involving ...

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced the initiation of its Phase 2 clinical study of investigational ...

Anil Oza is a general assignment reporter at STAT focused on the NIH and health equity. You can reach him on Signal at aniloza.16. A flurry of scientific gatherings and panels across federal science ...